The Pharmacokinetic-Pharmacodynamic Model of Azithromycin for Lipopolysaccharide-Induced Depressive-Like Behavior in Mice
A mechanism-based model was developed to describe the time course of lipopolysaccharide-induced depressive-like behavior and azithromycin pharmacodynamics in mice. The lipopolysaccharide-induced disease progression was monitored by lipopolysaccharide, proinflammatory cytokines, and kynrenine concent...
Main Authors: | Hao, Kun, Qi, Qu, Hao, Haiping, Wang, Guangji, Chen, Yuancheng, Liang, Yan, Xie, Lin |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554664/ |
Similar Items
-
The Pharmacokinetics and Pharmacodynamics of Iron Preparations
by: Geisser, Peter, et al.
Published: (2011) -
Pharmacokinetics of transfer of azithromycin into the breast milk of African mothers
by: Salman, S., et al.
Published: (2016) -
Chemical dampening of Ly6Chi monocytes in the periphery produces anti-depressant effects in mice
by: Zheng, Xiao, et al.
Published: (2016) -
Ketoprofen in the Cat: Pharmacodynamics and Chiral Pharmacokinetics
by: Lees, Peter, et al.
Published: (2003) -
Pharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies
by: Finley, Stacey D, et al.
Published: (2011)